Literature DB >> 26313326

Classification of different patterns of pulmonary adenocarcinomas.

Anna Truini1, Poliana Santos Pereira2, Alberto Cavazza3, Paolo Spagnolo4, Sofia Nosseir5, Lucia Longo6, Agita Jukna7, Filippo Lococo8, Giada Vincenzi9, Giuseppe Bogina10, Marcello Tiseo11, Giulio Rossi12.   

Abstract

The epidemic increase of adenocarcinoma histology accounting for more than 50% of primary lung malignancies and the advent of effective molecular targeted-therapies against specific gene alterations characterizing this tumor type have led to the reconsideration of the pathologic classification of lung cancer. The new 2015 WHO classification provided the basis for a multidisciplinary approach emphasizing the close correlation among clinical, radiologic and molecular characteristics and histopathologic pattern of lung adenocarcinoma. The terms 'bronchioloalveolar carcinoma' and 'mixed adenocarcinoma' have been eliminated, introducing the concepts of 'adenocarcinoma in situ', 'minimally invasive adenocarcinoma' and the use of descriptive predominant patterns in invasive adenocarcinomas (lepidic, acinar, papillary, solid and micropapillary patterns). 'Invasive mucinous adenocarcinoma' is the new definition for mucinous bronchioloalveolar carcinoma, and some variants of invasive adenocarcinoma have been included, namely colloid, enteric and fetal-type adenocarcinomas. A concise update of the immunomorphologic, radiological and molecular characteristics of the different histologic patterns of lung adenocarcinoma is reported here.

Entities:  

Keywords:  adenocarcinoma; epidermal growth factor receptor; ground-glass; immunohistochemistry; in-situ; lung; mucinous; pattern; thyroid transcription factor 1; v-ki-ras2 kirsten rat sarcoma viral oncogene homolog

Mesh:

Year:  2015        PMID: 26313326     DOI: 10.1586/17476348.2015.1083428

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  10 in total

1.  Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pulmonary Enteric Adenocarcinoma.

Authors:  Shuhei Teranishi; Chihiro Sugimoto; Hirokazu Nagayama; Wataru Segawa; Atsushi Miyasaka; Shuntaro Hiro; Chihiro Maeda; Hironori Tamura; Nami Masumoto; Yoshinori Nagahara; Nobuyuki Hirama; Nobuaki Kobayashi; Masaki Yamamoto; Makoto Kudo; Takeshi Kaneko
Journal:  Cancer Diagn Progn       Date:  2022-03-03

2.  Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.

Authors:  Jizhuang Luo; Rui Wang; Baohui Han; Jie Zhang; Heng Zhao; Wentao Fang; Qingquan Luo; Jun Yang; Yunhai Yang; Lei Zhu; Tianxiang Chen; Xinghua Cheng; Qingyuan Huang; Yiyang Wang; Jiajie Zheng; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-24       Impact factor: 4.553

3.  Prognostic factors in curatively resected pathological stage I lung adenocarcinoma.

Authors:  Yikun Yang; Yousheng Mao; Lin Yang; Jie He; Shugeng Gao; Juwei Mu; Qi Xue; Dali Wang; Jun Zhao; Yushun Gao; Zhirong Zhang; Ningning Ding; Ding Yang
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

4.  Non-Mucinous Lepidic Predominant Adenocarcinoma Presenting with Extensive Aerogenous Spread.

Authors:  Yusuke Takanashi; Shogo Tajima; Masaru Tsukui; Kazuya Shinmura; Takamitsu Hayakawa; Tsuyoshi Takahashi; Hiroshi Neyatani; Kazuhito Funai
Journal:  Rare Tumors       Date:  2016-12-07

5.  Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression.

Authors:  Domenico Trombetta; Paolo Graziano; Aldo Scarpa; Angelo Sparaneo; Giulio Rossi; Antonio Rossi; Massimo Di Maio; Davide Antonello; Andrea Mafficini; Federico Pio Fabrizio; Maria Carmina Manzorra; Teresa Balsamo; Flavia Centra; Michele Simbolo; Angela Pantalone; Michela Notarangelo; Paola Parente; Maria Cecilia Lucia Dimitri; Antonio Bonfitto; Fabiola Fiordelisi; Clelia Tiziana Storlazzi; Alberto L'Abbate; Marco Taurchini; Evaristo Maiello; Vito Michele Fazio; Lucia Anna Muscarella
Journal:  Oncotarget       Date:  2018-01-03

6.  Typical presentation of pulmonary lepidic adenocarcinoma: a rare case report.

Authors:  Rajae Azzeddine; Ismail Abderahmani Rhorfi; Adil Zegmout; Hicham Souhi; Hanane Elouazzani; Ahmed Abid; Hafsa Chahdi; Mohamed Tbouda
Journal:  Pan Afr Med J       Date:  2020-05-11

7.  Femoral head metastases from primary mucinous lung adenocarcinoma with left hip pain: A case report and literature review.

Authors:  Hang Xue; Wu Zhou; Zhenhe Zhang; Adriana C Panayi; Yuan Xiong; Shuhua Yang; Bobin Mi; Guohui Liu; Xianzhe Liu
Journal:  Front Surg       Date:  2022-09-20

Review 8.  Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review.

Authors:  Ying Cao; Li-Zhen Zhu; Meng-Jie Jiang; Ying Yuan
Journal:  Onco Targets Ther       Date:  2015-12-31       Impact factor: 4.147

9.  Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.

Authors:  Shasha Hou; Xiaoyun Lin; Shen Wang; Yiming Shen; Zhaowei Meng; Qiang Jia; Jian Tan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

10.  Prognosis of early stage pulmonary mucinous adenocarcinoma with different treatments.

Authors:  Jinyuan Liu; Shijiang Zhang; Jinhua Luo
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.